EICHOR
● Active Not Recruiting
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Condition: Chronic Limb-Threatening Ischemia · Sponsor: Cardiovascular and Interventional Radiological Society of Europe
About this study
CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (39)
| Krankenhaus der Barmherzigen Brüder | Eisenstadt, Austria | — |
| Medizinische Universität Graz | Graz, Austria | — |
| Krankenhaus Barmherzige Brüder Linz | Linz, Austria | — |
| Klinik Hietzing | Vienna, Austria | — |
| Klinik Florisdorf | Vienna, Austria | — |
| Hôpital Sacré Coeur de Montréal | Montreal, Canada | — |
| CHU François Mitterrand | Dijon, France | — |
| Institute Mutualiste Montsouris | Paris, France | — |
| Rhéna Clinique de Strasbourg | Strasbourg, France | — |
| Universitätsklinikum Köln | Cologne, Germany | — |
| Universitätsmedizin Essen | Essen, Germany | — |
| KRH Klinikum Robert Koch Gehrden | Hanover, Germany | — |
+ 27 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06149650